"Anemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
| Descriptor ID |
D000740
|
| MeSH Number(s) |
C15.378.071
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Anemia".
Below are MeSH descriptors whose meaning is more specific than "Anemia".
This graph shows the total number of publications written about "Anemia" by people in this website by year, and whether "Anemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1997 | 2 | 1 | 3 |
| 1998 | 2 | 0 | 2 |
| 1999 | 0 | 2 | 2 |
| 2000 | 4 | 0 | 4 |
| 2001 | 2 | 2 | 4 |
| 2002 | 8 | 1 | 9 |
| 2003 | 3 | 6 | 9 |
| 2004 | 5 | 0 | 5 |
| 2005 | 4 | 3 | 7 |
| 2006 | 4 | 2 | 6 |
| 2007 | 9 | 1 | 10 |
| 2008 | 6 | 2 | 8 |
| 2009 | 5 | 2 | 7 |
| 2010 | 8 | 1 | 9 |
| 2011 | 7 | 5 | 12 |
| 2012 | 3 | 0 | 3 |
| 2013 | 6 | 2 | 8 |
| 2014 | 6 | 5 | 11 |
| 2015 | 3 | 3 | 6 |
| 2016 | 8 | 4 | 12 |
| 2017 | 5 | 6 | 11 |
| 2018 | 5 | 2 | 7 |
| 2019 | 7 | 0 | 7 |
| 2020 | 6 | 3 | 9 |
| 2021 | 9 | 1 | 10 |
| 2022 | 21 | 0 | 21 |
| 2023 | 11 | 0 | 11 |
| 2024 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anemia" by people in Profiles.
-
Investigational drugs in early phase trials for myelofibrosis. Expert Opin Investig Drugs. 2024 Dec; 33(12):1231-1244.
-
Proposals for revised International Working Group-European LeukemiaNet criteria for anemia response in myelofibrosis. Blood. 2024 10 24; 144(17):1813-1820.
-
Red Blood Cell Transfusions in Patients with Advanced Cancer Receiving Home Palliative Care. J Palliat Med. 2024 Dec; 27(12):1639-1647.
-
Safety and efficacy of luspatercept for the treatment of anemia in?patients with myelofibrosis. Blood Adv. 2024 09 10; 8(17):4511-4522.
-
Sotatercept for anemia of myelofibrosis: a phase II investigator-initiated study. Haematologica. 2024 08 01; 109(8):2660-2664.
-
Transfusion-related cost offsets and time burden in patients with myelofibrosis on momelotinib vs. danazol from MOMENTUM. Future Oncol. 2024; 20(30):2259-2270.
-
Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial. Lancet Haematol. 2024 Sep; 11(9):e646-e658.
-
LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study. Lancet Oncol. 2024 Apr; 25(4):488-500.
-
Etiologies and Outcomes of Normocytic Anemia in Children. J Pediatr. 2024 Aug; 271:114041.
-
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial. Lancet. 2024 04 13; 403(10435):1460-1471.